Pharma year in review (Unknown)
In:
Chemical & Engineering News
;
94
, 48
;
36
;
2016
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Pharma year in review
-
Additional title:C&EN
-
Published in:Chemical & Engineering News ; 94, 48 ; 36
-
Publisher:
- New search for: American Chemical Society
-
Place of publication:Washington, DC
-
Publication date:2016-12-05
-
ISSN:
-
Coden:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:Unknown
-
Keywords:
-
Source:
Table of contents – Volume 94, Issue 48
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Table of Contents| 2016
- 2
-
Wrapping up 2016| 2016
- 5
-
Boron nitride converts propane to propene| 2016
- 7
-
ACS journals enact across-the-board safety policy| 2016
- 7
-
New tricks with aryl Grignards| 2016
- 7
-
Names for elements 113, 115, 117, and 118 finalized by IUPAC| 2016
- 8
-
Solar device desalinates water efficiently| 2016
- 8
-
Getting red blood cells to carry drugs| 2016
- 10
-
Bitterness in wild cucumber, melon, and watermelon| 2016
- 10
-
Polymer reduces drug conjugate immune reactions| 2016
- 10
-
Easily made antireflective coatings for flexible surfaces| 2016
- 11
-
Bismuth provides catalytic surprises| 2016
- 11
-
Coupling phenols and allylic alcohols| 2016
- 11
-
Layered structure improves patch conductivity| 2016
- 12
-
Companies invest in aquaculture ingredients| 2016
- 12
-
Japanese firms eye shale gas revolution| 2016
- 13
-
Axial debuts to link neuroscience and gut| 2016
- 13
-
Patheon acquires a Roche facility| 2016
- 13
-
Group grades retailers on safer chemicals in products| 2016
- 13
-
EPA flexes muscle under new TSCA| 2016
- 14
-
Pfizer invests in U.S., eases up in Ireland| 2016
- 14
-
Linde, Praxair merger talks back on again| 2016
- 14
-
CEFIC bemoans EU disclosure ruling| 2016
- 14
-
Givaudan expands in Singapore| 2016
- 14
-
Adidas kicks off spider silk shoes| 2016
- 14
-
Waters, Bruker back phenotype network| 2016
- 14
-
Drug firm may have used tainted heparin| 2016
- 14
-
Evonik clinches deal for biobased methionine| 2016
- 15
-
Sanofi gets Warp Drive aminoglycosides| 2016
- 15
-
Business Roundup| 2016
- 15
-
Arrowhead sheds programs, staff| 2016
- 15
-
J&J negotiates to buy Actelion| 2016
- 15
-
MedImmune, Abpro form research venture| 2016
- 16
-
Groups ask Trump to focus on science| 2016
- 17
-
Model predicts decline in Oklahoma temblors| 2016
- 17
-
Canada targets triclosan in wastewater| 2016
- 17
-
U.K. to ratify single EU patent system| 2016
- 17
-
CSB nominee has strong industry ties| 2016
- 18
-
Cautious optimism for an HIV vaccine| 2016
- 22
-
Growing pains in Cambridge, England| 2016
- 24
-
PPG counts on chemistry to give it an edge| 2016
- 26
-
C&EN talks with Kumudini Meepagala, mosquito repellent researcher| 2016
- 28
-
Industrial strength education| 2016
- 31
-
Perspectives: When are industries judged fairly?| 2016
- 34
-
Career Ladder: Elliot Richman| 2016
- 34
-
Classifieds| 2016
- 34
-
Ads| 2016
- 34
-
Masthead| 2016
- 36
-
Pharma year in review| 2016
- 37
-
Behind the EpiPen| 2016
- 38
-
AbbVie’s Humira held onto top spot despite biosimilar threat| 2016
- 38
-
Zika response in full gear| 2016
- 40
-
After the upset| 2016
- 41
-
Pharmaceutical firms saw mixed year in 2016| 2016
- 41
-
Eteplirsen controversy hit FDA| 2016
- 42
-
Biotech firms managed to go public in rocky year| 2016
- 42
-
Moonshot mania| 2016
- 43
-
Breakup of Pfizer and Allergan shaped the year| 2016
- 44
-
A focus on data| 2016
- 45
-
Why ACS approval matters for a chemistry program| 2016
- 46
-
Celebrating National Chemistry Week| 2016
- 50
-
Looking backward to move forward| 2016
- 56
-
Chemistry and Pop Culture Collide in New Novel and Possible TV Show| 2016